Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ARP2/3 complex mediates the neuropathology of PTEN-deficient human neural cells downstream of mTORC1 and mTORC2 hyperactivation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance.

Neuron·2026

Same author

Long-read proteogenomic atlas of human neuronal differentiation reveals isoform diversity informing neurodevelopmental risk mechanisms.

bioRxiv : the preprint server for biology·2025

Same author

Expanding the neuroimmune research toolkit with in vivo brain organoid technologies.

Disease models & mechanisms·2025

Same author

mTORC1 and mTORC2 synergy in human neural development, disease, and regeneration.

Neural regeneration research·2025

Same author

The use of a multi-metric readout screen to identify EHMT2/G9a-inhibition as a modulator of cancer-associated fibroblast activation state.

Biomaterials·2024

Search research articles

Related Experiment Video

Updated: Oct 10, 2025

Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro

Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro

Published on: May 5, 2022

Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and

Afrin Bhattacharya¹, Wendy W Y Choi², Julien Muffat³

¹Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada; The University of Toronto, Department of Molecular Genetics, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.

Journal of Molecular Biology

|December 9, 2021

Summary

Brain organoids offer a novel in vitro model for studying developmental brain diseases, overcoming limitations of traditional methods. These human stem cell-derived structures provide insights into disease mechanisms and potential treatments.

Keywords:

brain development disorder organoids technology

More Related Videos

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders

Published on: April 14, 2017

Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors

Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors

Published on: December 11, 2021

Related Experiment Videos

Last Updated: Oct 10, 2025

Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro

Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro

Published on: May 5, 2022

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders

Published on: April 14, 2017

Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors

Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors

Published on: December 11, 2021

Area of Science:

Neuroscience
Developmental Biology
Stem Cell Research

Background:

Developmental brain diseases stem from early life genetic or environmental factors.
Etiology and treatment of these conditions remain poorly understood due to disease heterogeneity and limitations of animal models.

Purpose of the Study:

To review the application of brain organoids in modeling human developmental brain diseases.
To discuss current progress, challenges, and future directions in this field.

Main Methods:

Utilizing brain organoids derived from human pluripotent stem cells.
Integrating advanced techniques like genome editing, tissue engineering, electrophysiology, and multi-omics analysis.

Main Results:

Brain organoids successfully recapitulate key developmental milestones of the early human brain.
These models offer valuable insights into the cellular and molecular mechanisms underlying normal and pathological brain development.

Conclusions:

Brain organoid technology represents a significant advancement in studying developmental brain diseases.
Further technological development is crucial to fully realize the potential of brain organoids for understanding and treating these complex conditions.